screen_shot_2012-07-03_at_10

ICON announces senior clinical and laboratory appointments

pharmafile | July 3, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ICON 

ICON, provider of outsourced development services to the pharma, biotech and medical device industries has announced appointments to the senior management teams of its clinical and central laboratories businesses.

Dr Nuala Murphy has been appointed executive VP, global clinical operations and data management, while Dr Mark Roseman (pictured) has joined ICON as executive VP, global scientific operations. Dr Era Khurana has joined ICON’s central laboratories’ leadership team as medical director.

Murphy has over 20 years’ experience within the pharmaceutical and CRO industries and joins ICON from Quintiles, where she managed clinical research professionals in Europe and Africa.

Advertisement

Roseman joins ICON with over 25 years of clinical research experience. Prior to ICON, he was executive VP of business development at Kendle/INC.

Khurana will provide scientific leadership and guidance and drive standards of performance and quality at ICON’s laboratories in Farmingdale, New York; Dublin, Ireland; Bangalore, India and Singapore. Khurana has over 28 years of pathology experience.

Commenting on the appointments, Ciaran Murray, chief executive at ICON, said: “I’m delighted to welcome Nuala, Mark and Era to the team at ICON. All three bring a wealth of operational, medical and therapeutic experience to ICON which we will leverage to support the design, planning and delivery of our clients’ drug development programmes.”

Related Content

cloud

Cloud on the horizon: Cloud computing and the clinical trial

 Originally published in the September edition of Pharmafocus, Matt Fellows investigates how cloud computing may …

ICON image

Icon to acquire Aptiv Solutions

Icon has acquired US clinical trial specialists Aptiv Solutions for $143.5 million as it looks …

Contract research news in brief

Icon offers $52m for CCH’s clinical services division, plus updates from PPD, Aptuit, Argenta, Quintiles …

The Gateway to Local Adoption Series

Latest content